Major players in the crypto industry are beginning to invest in biotech initiatives, applying blockchain principles for scientific progress.
Changpeng Zhao's Investments in Biotechnology
Binance founder Changpeng Zhao announced his personal donation of $10 million in BNB to Vitalik Buterin's open-source biotech initiatives. This donation is in addition to investments made by his family office, YZi Labs, in similar projects. Zhao believes that his contribution will help advance biotech.
Vitalik Buterin's Vision for Decentralized Biotech
Vitalik Buterin argues that modern science, especially biotech, is dominated by large corporations that often prioritize profit. He sees decentralization as a solution. According to Buterin, principles such as transparency, open-source development, and privacy characteristic of blockchain can foster scientific progress for everyone's benefit.
Advantages of Decentralized Science
Buterin points out that decentralized science can benefit fields like biotech by using tools such as zero-knowledge proofs to safeguard public health. He emphasizes the importance of transparency and empowering independent researchers to develop open vaccine protocols and rapid response tools for future pandemics.
In conclusion, crypto billionaires like Changpeng Zhao and Vitalik Buterin are leveraging their resources to fund innovations in biotechnology, which could lead to significant advancements in science.
